drugset
drugset / Trial / NCT04065919

Evaluation of Liposomal Bupivacaine Compared to Usual Care and Its Effects on Pain for Cardiac Surgery

NCT04065919 ↗

Phase 4 Unknown 300 enrolled Florida Heart and Lung Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of Liposomal Bupivacaine Compared to Usual Care and its Effect on Pain for Cardiac Surgery

Timeline

Start
2019-10-01
Primary completion
2020-10-30
Completion
2020-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 266 mg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.